Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Dubovsky

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Prostate|October 12, 2007
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitorJason A Dubovsky, Douglas G McNeel
Seminars in Hematology|July 23, 2014
The B-cell receptor pathway: a critical component of healthy and malignant immune biologyYiming Zhong, John C Byrd, Jason A Dubovsky
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
The biological basis for immunotherapy in patients with chronic myelogenous leukemiaJavier Pinilla-Ibarz, Bijal Shah, Jason A Dubovsky
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysisJason A Dubovsky, Mark R Albertini, Douglas G McNeel
Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs|December 6, 2016
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related DiseasesYiming Zhong, Amy J Johnson, John C Byrd, et al.
Cancer Immunity|January 13, 2006
Humoral immune responses to testis antigens in sera from patients with prostate cancerLuke H Hoeppner, Jason A Dubovsky, Edward J Dunphy, et al.
Chinese Clinical Oncology|December 11, 2013
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatmentsLaura E Johnson, Jordan T Becker, Jason A Dubovsky, et al.
Oncoimmunology|March 5, 2016
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cellsGayathri Natarajan, Cesar Terrazas, Steve Oghumu, et al.
Current Pharmaceutical Design|January 30, 2010
Circumventing immune tolerance through epigenetic modificationJason A Dubovsky, Alejandro Villagra, John J Powers, et al.
Leukemia Research|March 8, 2011
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidineJason A Dubovsky, John J Powers, Yang Gao, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Prostate|October 12, 2007
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitorJason A Dubovsky, Douglas G McNeel
Seminars in Hematology|July 23, 2014
The B-cell receptor pathway: a critical component of healthy and malignant immune biologyYiming Zhong, John C Byrd, Jason A Dubovsky
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
The biological basis for immunotherapy in patients with chronic myelogenous leukemiaJavier Pinilla-Ibarz, Bijal Shah, Jason A Dubovsky
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysisJason A Dubovsky, Mark R Albertini, Douglas G McNeel
Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs|December 6, 2016
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related DiseasesYiming Zhong, Amy J Johnson, John C Byrd, et al.
Cancer Immunity|January 13, 2006
Humoral immune responses to testis antigens in sera from patients with prostate cancerLuke H Hoeppner, Jason A Dubovsky, Edward J Dunphy, et al.
Chinese Clinical Oncology|December 11, 2013
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatmentsLaura E Johnson, Jordan T Becker, Jason A Dubovsky, et al.
Oncoimmunology|March 5, 2016
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cellsGayathri Natarajan, Cesar Terrazas, Steve Oghumu, et al.
Current Pharmaceutical Design|January 30, 2010
Circumventing immune tolerance through epigenetic modificationJason A Dubovsky, Alejandro Villagra, John J Powers, et al.
Leukemia Research|March 8, 2011
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidineJason A Dubovsky, John J Powers, Yang Gao, et al.
Pageof 3